Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice
Liver fibrosis is a common pathological feature of chronic hepatic injury that currently lacks effective therapeutic interventions. Albiflorin (ALB), a pinane-type monoterpene derived from Paeonia lactiflora Pall, has notable anti-inflammatory and hepatoprotective effects. However, the potential rol...
| Published in: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | Lingjie Meng, Huijing Lv, Anli Liu, Qian Cao, Xinyi Du, Chengjin Li, Qinggui Li, Qingqing Luo, Yi Xiao |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1577201/full |
Similar Items
Albiflorin: a promising natural monoterpene glycoside with potential therapeutic benefits for multiple physiological systems
by: Gui-Rong Li, et al.
Published: (2025-12-01)
by: Gui-Rong Li, et al.
Published: (2025-12-01)
Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome
by: Xiu Zhou, et al.
Published: (2019-10-01)
by: Xiu Zhou, et al.
Published: (2019-10-01)
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01)
by: Heinrich Eileen L, et al.
Published: (2012-04-01)
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
by: Rojin Sarallah, et al.
Published: (2025-02-01)
by: Rojin Sarallah, et al.
Published: (2025-02-01)
Iridoids in gardenia fruit: key components in liver disease therapy
by: Qian Cao, et al.
Published: (2025-09-01)
by: Qian Cao, et al.
Published: (2025-09-01)
Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance
by: Yunfu Lv, et al.
Published: (2023-08-01)
by: Yunfu Lv, et al.
Published: (2023-08-01)
CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
by: Wu Xia, et al.
Published: (2023-08-01)
by: Wu Xia, et al.
Published: (2023-08-01)
Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01)
by: Natalia Valdés, et al.
Published: (2024-09-01)
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)
by: Christian Koch, et al.
Published: (2022-12-01)
The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)
by: Chen Z, et al.
Published: (2025-05-01)
Albiflorin alleviates DSS-induced ulcerative colitis in mice by reducing inflammation and oxidative stress
by: Xiaohui Wang, et al.
Published: (2023-01-01)
by: Xiaohui Wang, et al.
Published: (2023-01-01)
Effects of albiflorin on oxidative stress and inflammatory responses in rats with acute spinal cord injury
by: Pengfei Fang, et al.
Published: (2023-09-01)
by: Pengfei Fang, et al.
Published: (2023-09-01)
Advances in CXCR7 Modulators
by: Nicole Lounsbury
Published: (2020-02-01)
by: Nicole Lounsbury
Published: (2020-02-01)
The role of CXCR3 and its ligands in cancer
by: Xiaoming Wang, et al.
Published: (2022-11-01)
by: Xiaoming Wang, et al.
Published: (2022-11-01)
Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
by: Zijian Pan, et al.
Published: (2022-03-01)
by: Zijian Pan, et al.
Published: (2022-03-01)
Albiflorin ameliorates thioacetamide-induced hepatic fibrosis: The involvement of NURR1-mediated inflammatory signaling cascades in hepatic stellate cells activation
by: Jian Song, et al.
Published: (2024-05-01)
by: Jian Song, et al.
Published: (2024-05-01)
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
by: Jan-Hendrik Bockmann, et al.
Published: (2025-03-01)
by: Jan-Hendrik Bockmann, et al.
Published: (2025-03-01)
CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
by: Seong-Kyu Kim, et al.
Published: (2023-02-01)
by: Seong-Kyu Kim, et al.
Published: (2023-02-01)
Elevated plasma CXCL12 leads to pain chronicity via positive feedback upregulation of CXCL12/CXCR4 axis in pain synapses
by: Shi-Ze Leng, et al.
Published: (2024-12-01)
by: Shi-Ze Leng, et al.
Published: (2024-12-01)
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
by: Tzu-Yi Chia, et al.
Published: (2024-01-01)
by: Tzu-Yi Chia, et al.
Published: (2024-01-01)
Curcumin inhibits ferroptosis-mediated vascular occlusion by regulating the CXCL10/CXCR3 axis in retinopathy of prematurity
by: Rui Niu, et al.
Published: (2025-03-01)
by: Rui Niu, et al.
Published: (2025-03-01)
Association of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients
by: Saba Gharibi, et al.
Published: (2022-10-01)
by: Saba Gharibi, et al.
Published: (2022-10-01)
Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL 11 in basal cell carcinoma
by: Mariya K Ansari, et al.
Published: (2023-01-01)
by: Mariya K Ansari, et al.
Published: (2023-01-01)
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop
by: Noor Abdala-Saleh, et al.
Published: (2024-10-01)
by: Noor Abdala-Saleh, et al.
Published: (2024-10-01)
Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01)
by: Lingli Wang, et al.
Published: (2025-04-01)
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma
by: Benjamin B. Gyau, et al.
Published: (2025-06-01)
by: Benjamin B. Gyau, et al.
Published: (2025-06-01)
CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
by: Marcelo G. Kazanietz, et al.
Published: (2019-07-01)
by: Marcelo G. Kazanietz, et al.
Published: (2019-07-01)
Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01)
by: Lingli Wang, et al.
Published: (2025-07-01)
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
by: Nathan Reynders, et al.
Published: (2019-06-01)
by: Nathan Reynders, et al.
Published: (2019-06-01)
Unveiling the role of CXCL8/CXCR2 in intervertebral disc degeneration: A path to promising therapeutic strategies
by: Pengfei Xue, et al.
Published: (2024-11-01)
by: Pengfei Xue, et al.
Published: (2024-11-01)
The role of CXCR3 and its ligands expression in Brucellar spondylitis
by: Xin Hu, et al.
Published: (2020-11-01)
by: Xin Hu, et al.
Published: (2020-11-01)
Blocking of the CXCR4-CXCL12 Interaction Inhibits the Migration of Chicken B Cells Into the Bursa of Fabricius
by: Maria Laparidou, et al.
Published: (2020-01-01)
by: Maria Laparidou, et al.
Published: (2020-01-01)
High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer
by: Shuning Xu, et al.
Published: (2025-05-01)
by: Shuning Xu, et al.
Published: (2025-05-01)
The utility of CXCL13 and circulating CXCR5+ T cell detection in the diagnosis of systemic lupus erythematosus associated nephritis
by: Yu Liu, et al.
Published: (2025-10-01)
by: Yu Liu, et al.
Published: (2025-10-01)
Involvement of chemokine CXCL12 and its receptor CXCR4 in uterine receptivity and potential relationship to fertility in cattle: a mini review
by: Michael J. D’Occhio, et al.
Published: (2025-08-01)
by: Michael J. D’Occhio, et al.
Published: (2025-08-01)
Extracellular Hsp70 Is Involved in the CXCL12/CXCR4 Pathway in Primary Human Nasal Epithelial Cells: A Preliminary Study
by: Seong Hee Kim, et al.
Published: (2023-11-01)
by: Seong Hee Kim, et al.
Published: (2023-11-01)
Nanoparticle‐Mediated CXCL12–CXCR4 Inhibition Reprograms Macrophages and Suppresses Gastric Carcinoma
by: Qianqian Cao, et al.
Published: (2025-08-01)
by: Qianqian Cao, et al.
Published: (2025-08-01)
Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
by: I. Aversa, et al.
Published: (2017-08-01)
by: I. Aversa, et al.
Published: (2017-08-01)
Intrauterine adhesions repair with menstrual blood-derived mesenchymal stem cells via CXCL13-CXCR5 signal axis and its mechanism
by: Bing Luo, et al.
Published: (2024-10-01)
by: Bing Luo, et al.
Published: (2024-10-01)
Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
by: Jing-Yi Hou, et al.
Published: (2023-04-01)
by: Jing-Yi Hou, et al.
Published: (2023-04-01)
Similar Items
-
Albiflorin: a promising natural monoterpene glycoside with potential therapeutic benefits for multiple physiological systems
by: Gui-Rong Li, et al.
Published: (2025-12-01) -
Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome
by: Xiu Zhou, et al.
Published: (2019-10-01) -
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01) -
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
by: Rojin Sarallah, et al.
Published: (2025-02-01) -
Iridoids in gardenia fruit: key components in liver disease therapy
by: Qian Cao, et al.
Published: (2025-09-01)
